HULC and cancer: To date, HULC was shown to be aberrantly expressed in many types of cancers (e.g., breast cancer, pancreatic cancer, bladder cancer, gliomas) and considered a probable diagnostic, prognostic biomarker and therapeutic target for a number of malignancies.